stella
beta
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma — Stella
Home
/
Nasopharyngeal Carcinoma
/
View on ClinicalTrials.gov
Recruiting
Back to Nasopharyngeal Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
18 Years – 75 Years
Last updated May 2023